期刊文献+

芪苈强心胶囊治疗慢性收缩性心力衰竭42例临床观察 被引量:6

Clinical observation on the therapeutic effect of Qiliqiangxin capsule on 42 cases of chronic contractive heart failure
在线阅读 下载PDF
导出
摘要 目的观察芪苈强心胶囊联合西药治疗中、重度慢性收缩性心力衰竭(CHF)的疗效。方法将84例CHF患者随机分为2组,对照组(42例)给予ACEI类、利尿剂、小剂量倍他乐克片(心功能IV级者心力衰竭控制后开始口服)、小剂量地高辛片等常规治疗左心衰竭;观察组(42例)在对照组治疗基础上加服芪苈强心胶囊(4粒,每日3次),2周时观察比较2组治疗效果。结果治疗2周后,观察组心功能改善总有效率、中医证候改善总有效率、左室射血分数(LVEF)提高率分别为92.9%、95.2%、(25±4)%,而对照组则分别为76.2%、81.0%、(11±3)%,2组比较差异有统计学意义(P<0.05或P<0.01)。2组均未发现明显不良反应。结论芪苈强心胶囊联合西药治疗中、重度CHF,可以更有效地改善心功能,缓解临床症状,提高左室射血分数,且安全性好。 Objective To observe the therapeutic effect of Qiliqiangxin capsule combined with western medicine on moderate and severe chronic contractive heart failure(CHF) .Methods 42 patients with CHF in control group were treated with ACEI, uretica, small dose of beta-blocker tablet (The patients with cardiac function IV grade didn' t take it until heart failure was controlled), small dose of digoxin. The 42 patients in observation group, on the basis of control group, were treated by Qiliqiangxin capsule, four pills once, three times a day. The therapeutic effects were observed and compared after two-week treatment in the two groups. Results After two-week treatment, the total effective rate of cardiac function improvement, total effective rate of improvement of TCM symptoms and increasing rate of left ventricle ejection fraction (LVEF) in observation group were 92.9 %, 95.2 %, (25±4) % respectively, but which in control group were 76.2%,81.0%, (11 ± 3)% respectively. There was a significant difference between the two groups ( P 〈 0.05 or P 〈 0.01 ). The side effects were not found in beth groups. Conclusion In the treatment of moderate and severe chronic contractive heart failure, Qiliqiangxin capsule combined with western medicine, could improve cardiac function effectively, alleviate clinical symptoms and increase LVEF, with safety.
出处 《疑难病杂志》 CAS 2007年第9期521-523,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 芪苈强心胶囊 心力衰竭 收缩性 慢性 Qiliqiangxin capsule Heart failure, contractive, chronic
  • 相关文献

参考文献7

二级参考文献34

  • 1Evidence-Based Medicine Working Group.Evidence-Based Medicine:a new approach toteaching the practice of medicine.JAMA,1992,268(17):2420-2425
  • 2Gavg R,Yusuf S.Overview of randomized trial of angiotensin converting enzymeinhibitors on mortality and morbidity in patients with heart failure.Collaborative Groupon ACE in-hibitors.JAMJ,1995,273(18):1450
  • 3ACC/AHA Task Force Report.Guideline for the evaluation and management of heartfailure.JACC,1995,26(5):1376-1398
  • 4Advisory Council to Imptove Outcome Nationwide in Heart Failure.Consensusrecommendations for the management of chronic heart failure.Am J Cardiol,1999,83(2A):1-30
  • 5CIBIS-ⅡInvestigators and Committees.The cardiac insuffi-ciency bisoprolol studyⅡ(CIBIS-Ⅱ)a randomised trial.Lancet,1999,353(9146):9
  • 6MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:MetoprololCR/XL Randomised Inter-vention Trial in congestive Heart Failure(MERIT-HF.Lancet,1999,353(9169):2001
  • 7Cleland JGF,McGowan J,Clark A.The evidence for β blockers in heartfailure.BMJ,1999,318(7187):824-825
  • 8Rahimtoola SH,Tak T.The use of digitalis in heart failure.Curr ProlCardiol,1996,21(2):781
  • 9Dangas G,Gorlin R.The role of digitalis in the management of heart failure:oldmolecule new respectability.In:Coats A,ed.Controversies in the management of heartfailure.Lond:Churchill Livingstone,1997.83-86
  • 10The Digitalis Investigation Group:The effect of digoxin on mortality and morbidityin patients with heart failure.N Engl J Med,1997,336(8):525-533

共引文献3394

同被引文献322

引证文献6

二级引证文献231

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部